Organization · Venture Capital
Epidarex Capital
Epidarex Capital is a transatlantic venture capital firm that invests in early-stage life science and health technology companies, with a focus on university spin-outs. Headquartered in Bethesda, Maryland, and Edinburgh, UK, it aims to address unmet medical needs through innovative healthcare solutions.
Overview
What Epidarex Capital does
What Epidarex Capital is
Epidarex Capital is a transatlantic venture capital firm that invests in early-stage life science and health technology companies, with a focus on university spin-outs. Headquartered in Bethesda, Maryland, and Edinburgh, UK, it aims to address unmet medical needs through innovative healthcare solutions.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2010
- Approximate age
- About 16 years
- Structured capabilities
- Funder
- Last reviewed
- May 1, 2026
Official channels
Find Epidarex Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Epidarex Capital as a funder
Investment thesis
Epidarex Capital focuses on translating breakthrough science into new life-science companies, targeting early-stage healthcare innovation sourced from established and emerging research hubs in the UK and US, particularly in therapeutics and medical devices.
Focus narrative
Epidarex Capital invests in early-stage life science opportunities, including biotechnology, pharmaceuticals, medical devices, and health technology. The firm typically provides seed or Series A funding to spin out innovations from leading medical research universities and institutions, targeting transformative technologies that address significant unmet medical needs.
Value beyond capital
Epidarex Capital adds value to its portfolio companies by providing access to scientific and industry networks, strategic guidance, board and advisory support, and co-investor coordination. The firm helps build leadership teams and shape company strategy, guiding startups through critical value inflection points.
Focus and fit
- Stages
- Seed · Series A · Friends and Family · Accelerator
Availability
- Currently deploying
- Yes
Portfolio and track record
Portfolio context
Epidarex Capital's notable portfolio includes: AdoRx Therapeutics: Developing modulators of the adenosine pathway for cancer treatment. Apellis Pharmaceuticals: Focused on therapies for diseases driven by the complement cascade. Caldan Therapeutics: Developing therapeutics targeting free fatty acid receptors for metabolic diseases. Clyde Biosciences: Innovating technology to evaluate cardiotoxicity risk in pharmaceuticals. Confluence Life Sciences: Focused on kinase inhibitors for cancer and inflammatory diseases. Curve Therapeutics: Developing therapeutics targeting protein-protein interactions. Dunad Therapeutics: Specializing in small molecule therapeutics for targeted protein degradation. Enterprise Therapeutics: Developing therapies for respiratory diseases. Harness Therapeutics: Focused on RNA-targeted therapies for neurodegenerative diseases. Lario Therapeutics: Developing precision medicines for neurological disorders. Leucid Bio: Innovating CAR-T therapies for cancer treatment. NodThera: Developing oral inhibitors for chronic inflammatory diseases. Kynos Therapeutics: Specializing in immunometabolic therapies.
Common questions
What to know about Epidarex Capital
Upseed classifies Epidarex Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 1, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.